New Technology by Cambridge University Ensures Sustained Release of Injections of Diabetes,Cancer and AIDS for up to Six months

A new technology which delivers sustained release of therapeutics for up to six months could be used in conditions which require routine injections, including diabetes, certain forms of cancer and potentially HIV/AIDS.

Researchers from the University of Cambridge have developed injectable, reformable and spreadable hydrogels which can be loaded with proteins or other therapeutics. The hydrogels contain up to 99.7% water by weight, with the remainder primarily made up of cellulose polymers held together with cucurbiturils – barrel-shaped molecules which act as miniature ‘handcuffs’.

read here

Unknown's avatar

About Rashid Faridi

I am Rashid Aziz Faridi ,Writer, Teacher and a Voracious Reader.
This entry was posted in News. Bookmark the permalink.

2 Responses to New Technology by Cambridge University Ensures Sustained Release of Injections of Diabetes,Cancer and AIDS for up to Six months

  1. lenrosen4's avatar lenrosen4 says:

    Thank you for alerting me to this new biotechnology. I will feature it in this week’s headlines and credit you as my blogging source.

    Like

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.